Observation of the growth of some adenineless mutants of Schizosaccharomyces pombe on six substituted purine analogs leads to the hypothesis that an enzyme is present which catalyzes the conversion of these analogs into hypoxanthine. The enzyme adenase (adenine aminohydrolase, EC 3.5.4.2) has been found to be active in cell-free extracts of S% pombe. Results are reported which are in agreement with the hypothesis that this enzyme is responsible for the in vivo utilization of 6-chloropurine. This evidence comes mainly from a study of adenine aminohydrolase in two mutants selected for partial inability to grow on 6-chloropurine.
Several purine analogs, bearing various substituents in position 6, support the growth of a number of adenineless mutants of Schizosaccharomyces pombe blocked before inosine monophosphate (IMP; Fig. 1 and Table 1 ). However mutants ade-2 and ade-8, blocked after IMP, cannot grow on these compounds. Various pathways are theoretically possible for the transformation of these purine analogs into IMP. The existence of an adenine aminohydrolase catalyzing the transformation of several purine analogs into hypoxanthine has been demonstrated in Candida utilis and Azotobacter vinelandii (4) . The possibility of such a direct conversion of the purine analogs by S. pombe adenase was considered here.
As adenine and 6-chloropurine are both substrates of adenine aminohydrolase in C. utilis and A. vinelandii, in vitro experiments were devised to test if these two compounds were effectively transformed into hypoxanthine by cell-free extract of S. pombe. Since the presence of hypoxanthine phosphoribosyltransferase in this organism has been confirmed (3), this enzyme accounts for the further conversion of hypoxanthine into IMP (Fig. 1 ).
MATERIALS AND METHODS Strains. The mutant strains were obtained after I hr of mutagenic treatment with nitrosomethylurethane 0.01% on the wild-type strain 972 of S. pombe (6) and plating the treated cell suspension on a minimum mineral medium supplemented with adenine (see below). Enzyme assays. Adenine aminohydrolase activity is assayed in the crude extract by incubating the substrate 14C-adenine and buffer A at pH 7 (see above; final concentrations of 10-4 and 7 x 10-2 M, respectively) for 4 min at 37 C. The final volume of the reaction mixture is 0.5 ml. The reaction is stopped by boiling in a water bath for 10 min and the precipitate is separated by centrifugation. Descending paper chromatography proved effective for separation of the reaction products present in 0.01 ml of the supernatant fluid. The two following systems both employed Whatman no. I paper.
(i) 5% (w/v) Na2HPO4-isoamylic alcohol (2:1, v/v) for adenine hypoxanthine separation. The RF values are 0.40 and 0.58 for adenine and hypoxanthine, respectively.
(ii) n-Butanol-formic acid-distilled water (15:3:2, v/v) for both adenine-hypoxanthine and 6-chloropurine-hypoxanthine separation. The RF values are 0.23, 0.30, and 0.75 for adenine, hypoxanthine, and 6-chloropurine, respectively. To confirm the identification of the reaction products, unlabeled adenine and hypoxanthine were added both as external and internal chromatographic control. For quantitative determination, the radioactivity of the spots on the paper was measured in a liquid scintillation spectrometer (Packard model 314 fx). The counting efficiency of 14C was 50%.
All the incubations were carried out in the conditions of linearity of time and enzyme concentration. The amount of soluble proteins in the cell-free extracts was measured by the method of Lowrv et al. (7) .
Adenine and 6-chloropurine uptake. The basic method described by Cummins and Mitchison (1) was followed. Cells were shaken for 16 hr at 30 C in the minimum mineral medium (see above) supplemented with adenine (20 mg/liter) and 6-chloropurine (20 mg/ liter), washed and suspended at 5 x 106 cells/ml density in prewarmed minimal medium containing either 1.5 x 10-4 M [8-14C]adenine or 1.5 x 10-4 M [8-'4C]chloropurine. Samples (2 ml) were removed at intervals and placed in tubes containing unlabeled adenine or 6-chloropurine. The samples were filtered, washed with 100 ml of distilled water containing unlabeled adenine and 6-chloropurine and finally counted in a liquid scintillation spectrometer.
Chemicals. Analogs mentioned in Table I were supplied by FLUKA AG, Buchs (Switzerland).
All of these chemicals were checked for purity by paper chromatography (see above). None of them was contaminated with hypoxanthine.
RESULTS
Growth of adenineless mutants on punne analogs. Table I shows the growth response of a number of adenineless mutants on minimal medium supplemented with one of a series of analogs substituted in position 6. The mutants can be separated into two classes: those which are affected in an enzymatic step preceding IMP, and which grow on the analogs; and the mutants ade-2 and ade-8 which are blocked after IMP and which fail to grow on these compounds. As both of these mutants are growing only when adenine is supplemented and behave after backcross with wild-type strain as single mutations, the possibility of an enzymatic block between hypoxanthine and IMP is excluded. This observation led us to assume that the purine analogs are precursors of IMP and the possible conversion of one of these substances, 6-chloropurine, after entry into the cell was investigated.
In vitro conversion of adenine and of 6-chloropurine by cell-free extracts of the adenineless mutant ade-l. We first established the existence of adenine aminohydrolase in cell-free extracts of the adenineless mutant ade-I (Fig. 1) . To explain the growth of adenineless mutants on purine analogs (Table I) , we investigated the conversion pathway of 6-chloropurine, one of these analogs. More precisely, the possibility of conversion of this compound into hypoxanthine, in a single step, was tested in vitro. Table 2 shows that adenine and 6-chloropurine are converted into hypoxanthine by cell-free extracts of the ade-l mutant. These results could account for the growth of ade-l on this analog.
Isolation of mutants of ade-1 growing slowly on 6-chloropurine. Uptake of this analog and adenine aminohydrolase characteristics of these mutants. Table 3 shows the growth response of ade-1 and of the two derived double-mutant strains, ade-l dea-l and ade-l dea-2, isolated as described above. The slow growth of the double mutants on 6-chloropurine can, a priori, have several explanations, e.g., the conversion of this analog into hypoxanthine proceeds at a lower speed, or the uptake of the analog is greatly reduced. The fact that the ade-J dea-I mutant grows on hypoxanthine excludes the possibility of an enzymatic block at the level of the hypoxanthine phosphoribosyltransferase.
To know whether the difference between the strains ade-), ade-l dea-1, and ade-l dea-2 could be explained at the level of the 6-chloropurine hydrolysis into hypoxanthine, this analog and adenine were incubated with cell-free extracts of each strain. verted into hypoxanthine to the same extent by crude extracts of the strains ade-1 and ade-l dea-1, but no hypoxanthine was found after incubation in the presence of the ade-l dea-2 extract. These in vitro results show clearly the role of adenine aminohydrolase in the utilization of 6-chloropurine by adenineless mutants; they explain the slow growth of ade-) dea-2 on 6-chloropurine, but do not account for the similar behavior of ade-1 dea-1.
Therefore, we performed uptake experiments of [6-14C] chloropurine into ade-J and ade-l dea-1. The results are summarized in Table 4 . These data show no evidence for the existence of a block in the uptake of 6-chloropurine by the ade-1 dea-J strain. We tested the hypothesis that adenine aminohydrolase of the double mutant ade-l dea-J, although it shows normal activity in vitro (Table  2) , has an alteration explaining the slow growth on 6-chloropurine. First, the possibility of an increased sensitivity of the adenine aminohydrolase to Cl-was investigated. Addition of Cl-to the incubation medium at a final concentration varying from 10-5 to 10-1 M had no effect on the activity of the enzyme contained in cell-free extracts of the strains ade-J and ade-l dea-1. Thus, this possibility had to be eliminated.
Secondly, the thermal inactivation patterns of adenine aminohydrolase contained in crude ex tracts of ade-l and ade-J dea-J were compared. Figure 2 shows the results of these experiments performed at three different temperatures. These data cannot directly account for the poor utilization in vivo of 6-chloropurine by the ade-l dea-l strain, but indicate that its adenine aminohydrolase is altered and so give some more evidence of the role of this enzyme in the utilization of 6-chloropurine by the adenineless mutants.
Genetic analysis did not show any close linkage relationship between dea-1 and dea-2 loci: among 14 asci isolated after a cross between ade-) dea-l and ade-l dea-2 strains, four were parental ditypes, two were non-parental ditypes and eight were tetratypes. DISCUSSION The in vitro results presented in this work show that one possibility for the utilization of 6-chloropurine, and more generally of the six-substituted purine analogs, by the adenineless mutants listed in Table 1 , is the direct hydrolysis of the analog to give hypoxanthine in a single step.
It is very likely that the same transformation also occurs in vivo. However, other utilization pathways, involving several steps, are also theoretically possible. As adenine phosphoribosyltransferase exists in S. pombe, one could suppose that 6-chloropurine gives rise to the corresponding nucleotide, which could later be transformed by AMP deaminase and give rise to IMP. Direct deamination of AMP to IMP is well known in human erythrocytes (9) and brain (2) and has also been postulated in Drosophila (5). However, physiological and genetical experiments lead us to conclude that there is no detectable AMP deaminase in S. pombe (8) . A second multistep pathway known to exist in S. pombe is the following:
Adenine AMP -adenosine 3 inosine 4 hypoxanthine
Step 3 is catalyzed by an adenosine deaminase. We have no direct proof that six substituted purine analogs can follow this pathway, but we consider it likely. This would explain why the strain ade-J dea-2, devoid of adenine aminohydrolase, grows however slowly on 6-chloropurine:
6-Chloropurine -1 6-chloropurine nucleotide 2 6-chloropurine nucleoside 3 inosine 4 hypoxanthine Such a scheme assumes that adenosine deaminase is able to hydrolyse 6-chloropurine nucleoside into inosine. It has been shown that the two independant genes dea-l and dea-2 control adenine aminohydrolase. In dea-1, the enzyme is still active in vitro but shows an altered thermal inactivation pattern; in dea-2, the catalytic activity is completely absent. At 
